Results 111 to 120 of about 21,545 (230)

PET-CMR in heart failure - synergistic or redundant imaging? [PDF]

open access: yes, 2017
Imaging in heart failure (HF) provides data for diagnosis, prognosis and disease monitoring. Both MRI and nuclear imaging techniques have been successfully used for this purpose in HF.
Quail, MA, Sinusas, AJ
core   +1 more source

Palinacousis in amyloidosis: exploring the hallucinatory phenomenon in brain pathology—a case report

open access: yesJournal of Medical Case Reports
Background Hereditary transthyretin amyloidosis, caused by transthyretin gene mutations, progresses with systemic impact and often presents peripheral neuropathy.
João Martins-Correia, Luísa Sousa
doaj   +1 more source

A mutation in transthyretin gene in a Mexican patient leading to hereditary amyloidosis: a case report

open access: yesJournal of Medical Case Reports
Background Transthyretin is a protein produced by the liver, and when normal, it carries out the role of transporting thyroid hormone and vitamin A in the body. Mutations in the gene that codes for this protein can cause it to misfold.
Muhammad Reebal Malik   +2 more
doaj   +1 more source

Orthotopic Liver Transplantation in Familial Amyloidotic Polyneuropathy Is Associated with Long-Term Progression of Renal Disease [PDF]

open access: yes, 2012
Orthotopic liver transplantation has become the treatment of choice for familial amyloidotic polyneuropathy. The aims of this study were to evaluate the renal complications post orthotopic liver transplantation in familial amyloidotic polyneuropathy and
Baptista, A   +6 more
core  

Case Report: Diagnosis of Dual-Biopsy Negative Severe Cardiac Amyloidosis [PDF]

open access: yes, 2016
INTRODUCTION Amyloidosis is a rare disorder that involves the deposition of misfolded protein in extracellular tissue. Disease manifestations vary depending on the affected organs.
Kasprowicz, MD, Eric, Lohr, MD, Kristin
core   +2 more sources

Widespread Skin Lesions in an Italian Man

open access: yes
JEADV Clinical Practice, Volume 5, Issue 1, Page 333-336, March 2026.
Rebecca Donadoni   +7 more
wiley   +1 more source

Treatment of transthyretin cardiac amyloidosis

open access: yesCurrent Opinion in Cardiology
Purpose of review Tafamidis is currently the only approved disease-modifying treatment for ATTR-CM. However, there have been important developments in the treatment of ATTR-CM, as the results of two phase 3 trials were published and several other trials are in their final stages.
Bampatsias, Dimitrios   +2 more
openaire   +2 more sources

Magnetic Resonance in Transthyretin Cardiac Amyloidosis

open access: yesJournal of the American College of Cardiology, 2017
Cardiac transthyretin amyloidosis (ATTR) is an increasingly recognized cause of heart failure. Cardiac magnetic resonance (CMR), with late gadolinium enhancement (LGE) and T1 mapping, is emerging as a reference standard for diagnosis and characterization of cardiac amyloidosis.The authors used CMR with extracellular volume fraction (ECV) measurement to
Martinez-Naharro, A   +17 more
openaire   +3 more sources

What's new in the treatment of amyloidosis? Part 2: Cardiomyopathy due to transthyretin amyloidosis

open access: yesRevista del Hospital Italiano de Buenos Aires
Transthyretin deposition amyloidosis is a rare disease caused by the deposition of fibrils of this protein in various tissues, although the most common manifestations are cardiac and neurological.
Gisela Bendelman   +10 more
doaj   +1 more source

Pompe Disease Could Mimic Exam Findings of Amyloidosis: Two Rare Diagnoses Bona Fide

open access: yesCase Reports in Hematology, 2018
A 70-year-old female presented with a three-year history of evolving macroglossia causing dysphagia and dysarthria, with proximal muscle weakness.
Jithma P. Abeykoon   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy